Atlas Trials

SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

Clinical trial NCT02819856 · COMPLETED

Trial details

NCT number
NCT02819856
Sponsor
Sound Pharmaceuticals, Incorporated
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ototoxicity
Start date
2017-07-21
Primary completion
2023-04-07
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.